Hemotune develops a magnetic blood purification platform utilizing nanotechnology to restore immune balance in patients experiencing septic shock. This therapeutic approach aims to improve patient outcomes by effectively removing harmful substances from the bloodstream.
Funding
$15.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Septic shock is a life-threatening condition characterized by an imbalanced immune response and the presence of harmful substances in the bloodstream, leading to poor patient outcomes. Current treatments often struggle to effectively restore immune balance in these patients.
Solution
Hemotune is developing a blood purification platform based on magnetic nanotechnology for restoring immune balance in patients experiencing septic shock. The HemoSystem uses magnetic beads to selectively remove a broad spectrum of pathogens, toxins, and inflammatory mediators from the patient's blood. By targeting multiple substances simultaneously, the system aims to address the complex and dynamic nature of septic shock, leading to improved patient outcomes. The multi-target precision medicine approach offers a potential breakthrough in blood purification.
Target Audience
The primary target audience includes clinicians and hospitals treating patients with septic shock.
Features
- Magnetic beads for capturing a wide range of pathogens, toxins, and inflammatory mediators
- Multi-target approach to address the complexity of septic shock
- Extracorporeal blood purification system